PRE PRENETICS GLOBAL LIMITED

Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call

Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call

CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced it will release financial results for the third quarter 2025 ended September 30, 2025 before market open on Monday, November 10, 2025. The Company will also hold its first ever earnings conference call the same day at 8:30 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.

Date:Monday, November 10, 2025
Time:8:30 a.m. Eastern Time
Dial-in:1-844-425-9470
International Dial-in:201-298-0878
Webcast



An audio replay of the webcast will be available on the Company’s investor relations website at .

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8 — its flagship consumer brand co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka — now the fastest-growing supplement brand globally, reaching $100 million in annual recurring revenue within just 11 months of launch — the fastest growth ever recorded in the global history of the supplements industry, even outpacing today’s leading AI startups.

As the first consumer health company to establish a Bitcoin Treasury, Prenetics continues to pioneer at the intersection of health innovation and digital assets — purchasing 1 Bitcoin per day, now totaling 382 BTC as of November 4, 2025.

Investor Relations Contact:



Angela Cheung

Investor Relations / Corporate Finance



EN
04/11/2025

Underlying

PREPRENETICS GLOBAL LIMITED

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmp...

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the fastest supplement company ever to reach $100M ARR in just 11 months Giannis unlocks 35 million followers across social channels - NBA broadcasted in 215 countries To learn more about Giannis and IM8, please visit NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent comp...

10h / 37m 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics' IM8 Partners with Superpower to Personalize the Future of S...

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade supplementation with 100+ biomarker blood testing.IM8's Daily Ultimate Essentials will be available in the Superpower supplement marketplace and featured, where biomarker data supports it, as one of Superpower's recommended foundational daily supplements in members' personalized health protocols. NEW YO...

March 24, 2026 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics to Participate in the 38th Annual ROTH Conference

Prenetics to Participate in the 38th Annual ROTH Conference NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA. Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throughout the conference. Management w...

March 18, 2026 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Authorizes $40 Million Share Repurchase Program

Prenetics Authorizes $40 Million Share Repurchase Program Management and Board Have Collectively Committed Up to $42.75 Million to Prenetics Stock Backed by $164 Million in Total Adjusted Liquidity, Zero Debt IM8 Targeting $180M to $200M in 2026 Full Year Revenue, and a Clear Path to Adjusted EBITDA Profitability by Q4 2027 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced that its Board of Directors (the “B...

March 6, 2026 1 EN
 PRESS RELEASE
Free
PRE PRENETICS GLOBA...

Prenetics Executives Execute Second Consecutive Round of Post-Earnings...

Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million -  CEO Danny Yeung makes personal investment in this round of approximately $750,000, up from investment of approximately $502,000 in November 2025 NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced that members of its execu...

March 3, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch